Support our Research. Project 1) We sequence patients with Epilepsy who are being treated with CBD. Our goal is to find a genetic signature for positive response to CBD. This information will assist parents in making important relocation decisions. Medicinal Genomics and Courtagen (Parent company) is sequencing over 100 Dravet syndrome patients with the hope […]
On Oct 8th 2013, Medicinal Genomics and Courtagen scientists published a method to navigate 1000s of human gene patents. The technique likely impact non human gene patents as well. 60 days later Altmetrics has it classified as in the top 5% of articles ever tracked. http://www.nature.com/nbt/journal/v31/n10/abs/nbt.2703.html Some Links to Blogs discussing this are here , here and here
- Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.
- Lithium Attenuates Cannabinoid-Induced Dependence in the Animal Model: Involvement of Phosphorylated ERK1/2 and GSK-3β Signaling Pathways.
- The "addicted" spine.
- Designer drugs. Patients may be using synthetic cannabinoids more than you think.